Guided Therapeutics (GTHP) EBITDA (2010 - 2026)
Guided Therapeutics (GTHP) posted EBITDA of -$710000.0 for Q4 2025, down 46.39% sequentially from -$485000.0 in Q3 2025, and down 32.96% YoY from -$1.1 million in Q4 2024.
Guided Therapeutics (GTHP) EBITDA (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported EBITDA for 16 years, with the latest figure at -$710000.0 in Q4 2025.
- Quarterly EBITDA fell 32.96% year-over-year to -$710000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.4 million (down 12.47% YoY) and the FY2025 annual result came in at -$2.4 million, down 12.52% from the prior year.
- EBITDA fell to -$710000.0 in Q4 2025 per GTHP's latest filing, from -$485000.0 in the prior quarter.
- Over five years, EBITDA peaked at -$359000.0 in Q1 2024 and troughed at -$1.5 million in Q2 2023.
- A 5-year average of -$678750.0 and a median of -$592000.0 in 2021 frame the typical range for EBITDA.
- The sharpest annual moves came in 2021 and 2024: EBITDA tumbled 240.08% in 2021, then soared 57.41% in 2024.
- Over 5 years, EBITDA stood at -$435000.0 in 2021, then plunged by 117.93% to -$948000.0 in 2022, then surged by 48.84% to -$485000.0 in 2023, then retreated by 10.1% to -$534000.0 in 2024, then sank by 32.96% to -$710000.0 in 2025.
- According to Business Quant data, EBITDA over the past three periods registered -$710000.0, -$485000.0, and -$763000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -478,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -478,000.00 |
| Dec 31, 2025 | -710,000.00 |
| Sep 30, 2025 | -485,000.00 |
| Jun 30, 2025 | -763,000.00 |
| Mar 31, 2025 | -414,000.00 |
| Dec 31, 2024 | -534,000.00 |
| Sep 30, 2024 | -561,000.00 |
| Jun 30, 2024 | -655,000.00 |
| Mar 31, 2024 | -359,000.00 |
| Dec 31, 2023 | -485,000.00 |
| Sep 30, 2023 | -623,000.00 |
| Jun 30, 2023 | -1.51 Mn |
| Mar 31, 2023 | -843,000.00 |
| Dec 31, 2022 | -948,000.00 |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -717,000.00 |
| Mar 31, 2022 | -443,000.00 |
| Dec 31, 2021 | -435,000.00 |
| Sep 30, 2021 | -487,000.00 |
| Jun 30, 2021 | -561,000.00 |